Pathological cell-cell interactions elicited by a neuropathogenic form of mutant huntingtin contribute to cortical pathogenesis in HD mice

Neuron

Volumn 46, Issue 3, 2005, Pages 433-444

  Gu, Xiaofeng ^a   Li, Chenjian ^b   Wei, Weizheng ^c   Lo, Victor ^a   Gong, Shiaoching ^d   Li, Shi Hua ^e   Iwasato, Takuji ^f,g   Itohara, Shigeyoshi ^f   Li, Xiao Jiang ^e   Mody, Istvan ^c   Heintz, Nathaniel ^d   Yang, X William ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d ROCKEFELLER UNIVERSITY   (United States)

^e EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f RIKEN BRAIN SCIENCE INSTITUTE   (Japan)

^g JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HUNTINGTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL AGGREGATION; CELL INTERACTION; CELL POPULATION; CELL TYPE; CONTROLLED STUDY; GENETICS; HUNTINGTON CHOREA; INTERNEURON; MOTOR DYSFUNCTION; MOUSE; NERVE CELL; NEUROPATHOLOGY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PYRAMIDAL NERVE CELL;

ANIMALS; BLOTTING, WESTERN; CELL COMMUNICATION; CEREBRAL CORTEX; DISEASE MODELS, ANIMAL; HUNTINGTON DISEASE; IMMUNOHISTOCHEMISTRY; MICE; MICE, MUTANT STRAINS; MICROSCOPY, ELECTRON, TRANSMISSION; MUTATION; NERVE TISSUE PROTEINS; NEURONS; NUCLEAR PROTEINS;

EID: 20944431926     PISSN: 08966273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuron.2005.03.025     Document Type: Article

References (70)

1. T.E. Anthony, C. Klein, G. Fishell, and N. Heintz Radial glia serve as neuronal progenitors in all regions of the central nervous system Neuron 41 2004 881 890
2. M. Arrasate, S. Mitra, E.S. Schweitzer, M.R. Segal, and S. Finkbeiner Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death Nature 431 2004 805 810
3. G.P. Bates Huntingtin aggregation and toxicity in Huntington's disease Lancet 361 2003 1642 1644
4. N.F. Bence, R.M. Sampat, and R.R. Kopito Impairment of the ubiquitin-proteasome system by protein aggregation Science 292 2001 1552 1555
5. D.L. Benson, P.J. Isackson, C.M. Gall, and E.G. Jones Contrasting patterns in the localization of glutamic acid decarboxylase and Ca2+/calmodulin protein kinase gene expression in the rat central nervous system Neuroscience 46 1992 825 849
6. C. Cepeda, R.S. Hurst, J. Flores-Hernandez, E. Hernandez-Echeagaray, G.J. Klapstein, M.K. Boylan, C.R. Calvert, E.L. Jocoy, O.K. Nguyen, and V.M. Andre Morphological and electrophysiological characterization of abnormal cell types in pediatric cortical dysplasia J. Neurosci. Res. 72 2003 472 486
7. A.M. Clement, M.D. Nguyen, E.A. Roberts, M.L. Garcia, S. Boillee, M. Rule, A.P. McMahon, W. Doucette, D. Siwek, and R.J. Ferrante Wild-type nonneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice Science 302 2003 113 117
8. N.O. Dalby, and I. Mody Activation of NMDA receptors in rat dentate gyrus granule cells by spontaneous and evoked transmitter release J. Neurophysiol. 90 2003 786 797
9. S.W. Davies, M. Turmaine, B.A. Cozens, M. DiFiglia, A.H. Sharp, C.A. Ross, E. Scherzinger, E.E. Wanker, L. Mangiarini, and G.P. Bates Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation Cell 90 1997 537 548
10. M. DiFiglia, E. Sapp, K.O. Chase, S.W. Davies, G.P. Bates, J.P. Vonsattel, and N. Aronin Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain Science 277 1997 1990 1993
11. A.W. Dunah, H. Jeong, A. Griffin, Y.M. Kim, D.G. Standaert, S.M. Hersch, M.M. Mouradian, A.B. Young, N. Tanese, and D. Krainc Sp1 and TAFII130 transcriptional activity disrupted in early Huntington's disease Science 296 2002 2238 2243
12. M.P. Duyao, A.B. Auerbach, A. Ryan, F. Persichetti, G.T. Barnes, S.M. McNeil, P. Ge, J.P. Vonsattel, J.F. Gusella, and A.L. Joyner Inactivation of the mouse Huntington's disease gene homolog Hdh Science 269 1995 407 410
13. I. Ferrer, J. Kulisevsky, G. Gonzalez, A. Escartin, A. Chivite, and R. Casas Parvalbumin-immunoreactive neurons in the cerebral cortex and striatum in Huntington's disease Neurodegeneration 3 1994 169 173
14. J. Gafni, E. Hermel, J.E. Young, C.L. Wellington, M.R. Hayden, and L.M. Ellerby Inhibition of calpain cleavage of huntingtin reduces toxicity: accumulation of calpain/caspase fragments in the nucleus J. Biol. Chem. 279 2004 20211 20220
15. L.R. Gauthier, B.C. Charrin, M. Borrell-Pages, J.P. Dompierre, H. Rangone, F.P. Cordelieres, J. De Mey, M.E. MacDonald, V. Lessmann, S. Humbert, and F. Saudou Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules Cell 118 2004 127 138
16. J.A. Gorski, T. Talley, M. Qiu, L. Puelles, J.L. Rubenstein, and K.R. Jones Cortical excitatory neurons and glia, but not GABAergic neurons, are produced in the Emx1-expressing lineage J. Neurosci. 22 2002 6309 6314
17. I. Gourfinkel-An, K. Parain, A. Hartmann, L. Mangiarini, A. Brice, G. Bates, and E.C. Hirsch Changes in GAD67 mRNA expression evidenced by in situ hybridization in the brain of R6/2 transgenic mice J. Neurochem. 86 2003 1369 1378
18. T. Grunewald, and M.F. Beal Bioenergetics in Huntington's disease Ann. N Y Acad. Sci. 893 1999 203 213
19. S. Gunawardena, L.S. Her, R.G. Brusch, R.A. Laymon, I.R. Niesman, B. Gordesky-Gold, L. Sintasath, N.M. Bonini, and L.S. Goldstein Disruption of axonal transport by loss of huntingtin or expression of pathogenic polyQ proteins in Drosophila Neuron 40 2003 25 40
20. C.A. Gutekunst, S.H. Li, H. Yi, J.S. Mulroy, S. Kuemmerle, R. Jones, D. Rye, R.J. Ferrante, S.M. Hersch, and X.J. Li Nuclear and neuropil aggregates in Huntington's disease: relationship to neuropathology J. Neurosci. 19 1999 2522 2534
21. A.S. Hackam, R. Singaraja, C.L. Wellington, M. Metzler, K. McCutcheon, T. Zhang, M. Kalchman, and M.R. Hayden The influence of huntingtin protein size on nuclear localization and cellular toxicity J. Cell Biol. 141 1998 1097 1105
22. J.G. Hodgson, N. Agopyan, C.A. Gutekunst, B.R. Leavitt, F. LePiane, R. Singaraja, D.J. Smith, N. Bissada, K. McCutcheon, and J. Nasir A YAC mouse model for Huntington's disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration Neuron 23 1999 181 192
23. T. Iwasato, A. Datwani, A.M. Wolf, H. Nishiyama, Y. Taguchi, S. Tanegawa, T. Knopfel, R.S. Erzurumlu, and S. Itohara Cortex-restricted disruption of NMDAR1 impairs neuronal patterns in the barrel cortex Nature 406 2000 726 731
24. G.R. Jackson, I. Salecker, X. Dong, X. Yao, N. Arnheim, P.W. Faber, M.E. MacDonald, and S.L. Zipursky Polyglutamine-expanded human huntingtin transgenes induce degeneration of Drosophila photoreceptor neurons Neuron 21 1998 633 642
25. A. Kazantsev, E. Preisinger, A. Dranovsky, D. Goldgaber, and D. Housman Insoluble detergent-resistant aggregates form between pathological and nonpathological lengths of polyglutamine in mammalian cells Proc. Natl. Acad. Sci. USA 96 1999 11404 11409
26. Y.J. Kim, Y. Yi, E. Sapp, Y. Wang, B. Cuiffo, K.B. Kegel, Z.H. Qin, N. Aronin, and M. DiFiglia Caspase 3-cleaved N-terminal fragments of wild-type and mutant huntingtin are present in normal and Huntington's disease brains, associate with membranes, and undergo calpain-dependent proteolysis Proc. Natl. Acad. Sci. USA 98 2001 12784 12789
27. I.A. Klement, P.J. Skinner, M.D. Kaytor, H. Yi, S.M. Hersch, H.B. Clark, H.Y. Zoghbi, and H.T. Orr Ataxin-1 nuclear localization and aggregation: role in polyglutamine-induced disease in SCA1 transgenic mice Cell 95 1998 41 53
28. C.M. Kosinski, J.H. Cha, A.B. Young, L. Mangiarini, G. Bates, J. Schiefer, and M. Schwarz Intranuclear inclusions in subtypes of striatal neurons in Huntington's disease transgenic mice Neuroreport 10 1999 3891 3896
29. G.A. Laforet, E. Sapp, K. Chase, C. McIntyre, F.M. Boyce, M. Campbell, B.A. Cadigan, L. Warzecki, D.A. Tagle, and P.H. Reddy Changes in cortical and striatal neurons predict behavioral and electrophysiological abnormalities in a transgenic murine model of Huntington's disease J. Neurosci. 21 2001 9112 9123
30. B.R. Leavitt, C.L. Wellington, and M.R. Hayden Recent insights into the molecular pathogenesis of Huntington disease Semin. Neurol. 19 1999 385 395
31. H. Li, S.H. Li, H. Johnston, P.F. Shelbourne, and X.J. Li Amino-terminal fragments of mutant huntingtin show selective accumulation in striatal neurons and synaptic toxicity Nat. Genet. 25 2000 385 389
32. J.C. Lievens, B. Woodman, A. Mahal, O. Spasic-Boscovic, D. Samuel, L. Kerkerian-Le Goff, and G.P. Bates Impaired glutamate uptake in the R6 Huntington's disease transgenic mice Neurobiol. Dis. 8 2001 807 821
33. A. Lunkes, K.S. Lindenberg, L. Ben-Haiem, C. Weber, D. Devys, G.B. Landwehrmeyer, J.L. Mandel, and Y. Trottier Proteases acting on mutant huntingtin generate cleaved products that differentially build up cytoplasmic and nuclear inclusions Mol. Cell 10 2002 259 269
34. R. Luthi-Carter, A. Strand, N.L. Peters, S.M. Solano, Z.R. Hollingsworth, A.S. Menon, A.S. Frey, B.S. Spektor, E.B. Penney, and G. Schilling Decreased expression of striatal signaling genes in a mouse model of Huntington's disease Hum. Mol. Genet. 9 2000 1259 1271
35. L. Mangiarini, K. Sathasivam, M. Seller, B. Cozens, A. Harper, C. Hetherington, M. Lawton, Y. Trottier, H. Lehrach, S.W. Davies, and G.P. Bates Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice Cell 87 1996 493 506
36. D. Martindale, A. Hackam, A. Wieczorek, L. Ellerby, C. Wellington, K. McCutcheon, R. Singaraja, P. Kazemi-Esfarjani, R. Devon, and S.U. Kim Length of huntingtin and its polyglutamine tract influences localization and frequency of intracellular aggregates Nat. Genet. 18 1998 150 154
37. C.A. Meade, Y.P. Deng, F.R. Fusco, N. Del Mar, S. Hersch, D. Goldowitz, and A. Reiner Cellular localization and development of neuronal intranuclear inclusions in striatal and cortical neurons in R6/2 transgenic mice J. Comp. Neurol. 449 2002 241 269
38. L.B. Menalled, and M.F. Chesselet Mouse models of Huntington's disease Trends Pharmacol. Sci. 26 2002 32 39
39. L.B. Menalled, J.D. Sison, Y. Wu, M. Oliveri, X.J. Li, H. Li, S. Zeitlin, and M.F. Chesselet Early motor dysfunction and striosomal distribution of huntingtin microaggregates in Huntington's disease knock-in mice J. Neurosci. 22 2002 8266 8276
40. I. Mody, and R.A. Pearce Diversity of inhibitory neurotransmission through GABA(A) receptors Trends Neurosci. 27 2004 569 575
41. P.J. Muchowski, G. Schaffar, A. Sittler, E.E. Wanker, M.K. Hayer-Hartl, and F.U. Hartl Hsp70 and hsp40 chaperones can inhibit self-assembly of polyglutamine proteins into amyloid-like fibrils Proc. Natl. Acad. Sci. USA 97 2000 7841 7846
42. A. Nagy Cre recombinase: the universal reagent for genome tailoring Genesis 26 2000 99 109
43. M.A. Nance, and R.H. Myers Juvenile onset Huntington's disease - clinical and research perspectives Ment. Retard. Dev. Disabil. Res. Rev. 7 2001 153 157
44. A.V. Panov, C.A. Gutekunst, B.R. Leavitt, M.R. Hayden, J.R. Burke, W.J. Strittmatter, and J.T. Greenamyre Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines Nat. Neurosci. 5 2002 731 736
45. G. Paxinos, and K.B.J. Franklin The Mouse Brain in Stereotaxic Coordinates Second Edition 2001 Academic Press San Diego
46. J.L. Ridet, S.K. Malhotra, A. Privat, and F.H. Gage Reactive astrocytes: cellular and molecular cues to biological function Trends Neurosci. 12 1997 570 577
47. C.A. Ross Polyglutamine pathogenesis: emergence of unifying mechanisms for Huntington's disease and related disorders Neuron 35 2002 819 822
48. C.A. Ross Huntington's disease: new paths to pathogenesis Cell 118 2004 4 7
49. E. Sapp, K.B. Kegel, N. Aronin, T. Hashikawa, Y. Uchiyama, K. Tohyama, P.G. Bhide, J.P. Vonsattel, and M. DiFiglia Early and progressive accumulation of reactive microglia in the Huntington disease brain J. Neuropathol. Exp. Neurol. 60 2001 161 172
50. G. Schilling, A.H. Sharp, S.J. Loev, M.V. Wagster, S.H. Li, O.C. Stine, and C.A. Ross Expression of the Huntington's disease (IT15) protein product in HD patients Hum. Mol. Genet. 4 1995 1365 1371
51. G. Schilling, M.W. Becher, A.H. Sharp, H.A. Jinnah, K. Duan, J.A. Kotzuk, H.H. Slunt, T. Ratovitski, J.K. Cooper, and N.A. Jenkins Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin Hum. Mol. Genet. 8 1999 397 407
52. A.H. Sharp, S.J. Loev, G. Schilling, S.H. Li, X.J. Li, J. Bao, M.V. Wagster, J.A. Kotzuk, J.P. Steiner, and A. Lo Widespread expression of Huntington's disease gene (IT15) protein product Neuron 14 1995 1065 1074
53. P. Somogyi, G. Tamas, R. Lujan, and E.H. Buhl Salient features of synaptic organisation in the cerebral cortex Brain Res. Brain Res. Rev. 26 1998 113 135
54. P. Soriano Generalized lacZ expression with the ROSA26 Cre reporter strain Nat. Genet. 21 1999 70 71
55. S. Srinivas, T. Watanabe, C.S. Lin, C.M. William, Y. Tanabe, T.M. Jessell, and F. Costantini Cre reporter strains produced by target insertion of EYFP and ECFP into the ROSA26 locus BMC Dev. Biol. 1 2001 4
56. J.S. Steffan, N. Agrawal, J. Pallos, E. Rockabrand, L.C. Trotman, N. Slepko, K. Illes, T. Lukacsovich, Y.Z. Zhu, and E. Cattaneo SUMO modification of Huntingtin and Huntington's disease pathology Science 304 2004 100 104
57. The Huntington's Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes Cell 72 1993 971 983
58. A.J. Tobin, and E.R. Signer Huntington's disease: the challenge for cell biologist Trends Cell Biol. 10 2000 531 536
59. F. Tronche, C. Kellendonk, O. Kretz, P. Gass, K. Anlag, P.C. Orban, R. Bock, R. Klein, and G. Schutz Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety Nat. Genet. 23 1999 99 103
60. Y. Trottier, Y. Lutz, G. Stevanin, G. Imber, D. Devys, G. Cancel, F. Saudou, C. Weber, G. David, and L. Tora Polyglutamine expansion as pathological epitope in Huntington's disease and four dominant cerebellar ataxias Nature 378 1995 403 406
61. M. Turmaine, A. Raza, A. Mahal, L. Mangiarini, G.P. Bates, and S.W. Davies Nonapoptotic neurodegeneration in a transgenic mouse model of Huntington's disease Proc. Natl. Acad. Sci. USA 97 2000 8093 8097
62. J.P. Vonsattel, and M. DiFiglia Huntington disease J. Neuropathol. Exp. Neurol. 57 1998 369 384
63. C.L. Wellington, L.M. Ellerby, C.A. Gutekunst, D. Rogers, S. Warby, R.K. Graham, O. Loubser, J. van Raamsdonk, R. Singaraja, and Y.Z. Yang Caspase cleavage of mutant huntingtin precedes neurodegeneration in Huntington's disease J. Neurosci. 22 2002 7862 7872
64. A. Yamamoto, J.J. Lucas, and R. Hen Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease Cell 101 2000 57 66
65. Z.X. Yu, S.H. Li, J. Evans, A. Pillarisetti, H. Li, and X.J. Li Mutant huntingtin causes context-dependent neurodegeneration in mice with Huntington's disease J. Neurosci. 23 2003 2193 2202
66. B.P. Zambrowicz, A. Imamoto, S. Fiering, L.A. Herzenber, W.G. Kerr, and P. Soriano Disruption of overlapping transcripts in the ROSA beta geo 26 gene trap strain leads to widespread expression of beta-galactosidase in mouse embryos and hematopoietic cells Proc. Natl. Acad. Sci. USA 94 1997 3789 3794
67. M.M. Zeron, O. Hansson, N. Chen, C.L. Wellington, B.R. Leavitt, P. Brundin, M.R. Hayden, and L.A. Raymond Increased sensitivity to N-methyl-D-aspartate receptor mediated excitotoxicity in a mouse model of Huntington's disease Neuron 33 2002 849 860
68. H. Zhou, F. Cao, Z. Wang, Z.X. Yu, H.P. Nguyen, J. Evans, S.H. Li, and X.J. Li Huntingtin forms toxic NH2-terminal fragment complexes that are promoted by the age-dependent decrease in proteasome activity J. Cell Biol. 163 2003 109 118
69. H.Y. Zoghbi, and H.T. Orr Glutamine repeats and neurodegeneration Annu. Rev. Neurosci. 23 2000 217 247
70. C. Zuccato, A. Ciammola, D. Rigamonti, B.R. Leavitt, D. Goffredo, L. Conti, M.E. MacDonald, R.M. Friedlander, V. Silani, and M.R. Hayden Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease Science 293 2001 493 498